ZEVRA THERAPEUTICS, INC.
Customers
0
None disclosed
Suppliers
1
0 disclosed
Latest period
Dec 31, 2023
10-K filed 2025-03-05
Suppliers 1
Companies that disclose ZVRA as a major customer, as a share of their own revenue. 0 active, 1 lapsed.
| Company | % of their revenue | Est. $ from ZVRA | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| AQST Aquestive Therapeutics, Inc. |
Named | — | FY 2023-12-31 | — | Lapsed Last seen 2023-12-31 |
10-K 2025-03-05 |
As of December 31, 2023, Indivor and Zevra Therapeutics, Inc. exceeded the 10% threshold for outstanding receivable balances and represented 65% and 13%, respectively of total trade and other receivables. | ||||||
Alerts are coming
Get an email when ZVRA's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.